Internal Medicine, Endocrinology, Diabetes, & Metabolism · Yuba City, CA
NPI
1790800035
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
400 Plumas Blvd
Yuba City, CA, 95991
Phone (530) 749-3520
Groups this clinician bills Medicare through
Medicare paid, 2024
$350K
18,258 services
Medicare patients, 2024
1,020
Average age 72
Drug cost, 2024
$2.4M
4,827 prescriptions
Company payments, 2023
$86.94
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harinder Singh was code J0897 (injection, denosumab, 1 mg), 7,200 times for 71 patients. In total Harinder Singh billed 18,258 services in 19 codes, and Medicare paid $350K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,200 | 71 | $20.10 | $145K |
| 99214 Office E&M - Established | Office | 1,451 | 856 | $91.47 | $133K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 566 | 471 | $13.04 | $7,381 |
| 95251 Test - Miscellaneous | Office | 549 | 244 | $25.72 | $14K |
| 99204 Office E&M - New | Office | 224 | 224 | $113.69 | $25K |
| 96372 Injection Administration | Office | 206 | 82 | $11.15 | $2,296 |
| 99215 Office E&M - Established | Office | 37 | 36 | $132.09 | $4,887 |
| 99205 Office E&M - New | Office | 24 | 24 | $160.20 | $3,845 |
| 10005 Other Organ Systems | Office | 13 | 11 | $110.35 | $1,435 |
By year: 2022 $259K for 20,102 services; 2023 $305K for 24,694 services; 2024 $350K for 18,258 services.
Medicare prescription drug claims, 2024
In 2024, the drug Harinder Singh prescribed most often to Medicare patients was Levothyroxine Sodium, with 454 prescriptions and refills. In total Harinder Singh wrote 4,827 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 454 | 1,221 | 124 | $5,806 |
| Ozempic Semaglutide | 377 | 609 | 87 | $520K |
| Metformin Hcl Generic | 243 | 624 | 72 | $2,431 |
| Jardiance Empagliflozin | 225 | 475 | 54 | $260K |
| Glipizide Generic | 219 | 565 | 69 | $1,689 |
| Trulicity Dulaglutide | 174 | 253 | 39 | $236K |
| Methimazole Generic | 158 | 334 | 42 | $2,041 |
| Synthroid Levothyroxine Sodium | 136 | 334 | 34 | $14K |
| Tresiba Flextouch U-100 Insulin Degludec | 121 | 345 | 41 | $75K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 118 | 238 | 30 | $77K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 113 | 298 | 44 | $19K |
| Humalog Kwikpen U-100 Insulin Lispro | 112 | 256 | 41 | $59K |
| Novolog Flexpen Insulin Aspart | 111 | 177 | 37 | $30K |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 111 | 194 | 42 | $110K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 95 | 244 | 45 | $17K |
Brand drugs: 2,713 claims; generic drugs: 1,724 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Harinder Singh $86.94 ($86.94 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $57.9.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 1 | $57.9 |
| Radius Health, Inc. | 2 | $29.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.